Abstract:Osteoarthritis (OA) is a degenerative joint disease and is the main cause of chronic pain and functional disability in adults. Articular cartilage is a hydrated soft tissue that is composed of normally quiescent chondrocytes at a low density, a dense network of collagen fibrils with a pore size of 60-200 nm, and aggrecan proteoglycans with high-density negative charge. Although certain drugs, nucleic acids, and proteins have the potential to slow the progression of OA and restore the joints, these treatments have not been clinically applied owing to the lack of an effective delivery system capable of breaking through the cartilage barrier. Recently, the development of nanotechnology for delivery systems renders new ideas and treatment methods viable in overcoming the limited penetration. In this review, we focus on current research on such applications of nanotechnology, including exosomes, protein-based cationic nanocarriers, cationic liposomes/solid lipid nanoparticles, amino acid-based nanocarriers, polyamide derivatives-based nanocarriers, manganese dioxide, and carbon nanotubes. Exosomes are the smallest known nanoscale extracellular vesicles, and they can quickly deliver nucleic acids or proteins to the required depth. Through electrostatic interactions, nanocarriers with appropriate balance in cationic property and particle size have a strong ability to penetrate cartilage. Although substantial preclinical evidence has been obtained, further optimization is necessary for clinical transformation. STATEMENT OF SIGNIFICANCE: The dense cartilage matrix with high-negative charge was associated with reduced therapeutic effect in osteoarthritis patients with deep pathological changes. However, a systematic review in nanodevices for deep cartilage penetration is still lacking. Current approaches to assure penetration of nanosystems into the depth of cartilage were reviewed, including nanoscale extracellular vesicles from different cell lines and nanocarriers with appropriate balance in cationic property and size particle. Moreover, nanodevices entering clinical trials and further optimization were also discussed, providing important guiding significance to future research.

Cartilage-targeting drug delivery: can electrostatic interactions help?

Biomaterial-mediated Delivery of Microenvironmental Cues for Repair and Regeneration of Articular Cartilage.

Cartilage-targeted drug nanocarriers for osteoarthritis therapy

Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy

Nanodevices for deep cartilage penetration

Advancing drug delivery to articular cartilage: From single to multiple strategies

Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage

Characterization of Calcium- and Strontium-Polyphosphate Particles Toward Drug Delivery into Articular Cartilage

Charge‐Reversed Exosomes for Targeted Gene Delivery to Cartilage for Osteoarthritis Treatment

Poly beta amino ester coated emulsions of NSAIDs for cartilage treatment

Intra‐Articular Injectable Biomaterials: Therapeutic Delivery for Cartilage Repair and Regeneration

Nanoarchitectonics of Injectable Biomimetic Conjugates for Cartilage Protection and Therapy Based on Degenerative Osteoarthritis Progression

Controlled Stimulus-Responsive Delivery Systems for Osteoarthritis Treatment

Development of Targeted Nanoscale Drug Delivery System for Osteoarthritic Cartilage Tissue

Polymer particles for the intra-articular delivery of drugs to treat osteoarthritis

Charge‐Guided Micro/Nano‐Hydrogel Microsphere for Penetrating Cartilage Matrix

Cationic micelles as nanocarriers for enhancing intra-cartilage drug penetration and retention

Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers

Ε-Poly-l-lysine As an Efficient Cartilage Penetrating and Residing Drug Carrier with High Intraarticular Injection Safety for Treating Osteoarthritis

Targeted and responsive biomaterials in osteoarthritis

Co‐Polymer Carrier with Dual Advantages of Cartilage‐Penetrating and Targeting Improves Delivery and Efficacy of microRNA Treatment of Osteoarthritis